Every month, up to 6.4 million searches related to cannabidiol (CBD) are performed by American adults looking to obtain information or buy products. CBD search queries eclipse those for other natural medical alternatives by a significant percentage.
Study provides further evidence the endocannabinoid system plays a crucial role in obsessive-compulsive disorder (OCD). Using cannabinoid drugs have a positive impact in helping control behaviors associated with OCD.
A new study considers the medical benefits of using marijuana to help treat epilepsy which can not be controlled with standard anticonvulsants.
A new PNAS paper reports cannabidiol can help reduce epileptic seizures and improve social behaviors in children with Dravet syndrome.
Cannabidiol may be able to bypass the blood-brain barrier to effectively deliver medications directly to the brain.
Cannabidiol (CBD) increases cerebral blood flow to areas of the brain associated with memory processing, specifically the hippocampus. The findings identify a potential mechanism for the use of CBD to treat disorders associated with altered memory processing, including Alzheimer's disease, PTSD, and schizophrenia.
Cannabidiol (CBD), a non-psychoactive compound extract of marijuana, has the potential to be used as an antibiotic. Researchers found CBD was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that are resistant to common antibiotics. Additionally, CBD does not lose its effectiveness after extended treatment.
Cannabidiol (CBD) can inhibit aggressiveness associated with social isolation, a new mouse model study reveals.
A study using rat models of depression reveals a single dose of the cannabis extract CBD can help to reduce symptoms of depression for up to one week. Researchers say cannabidiol appears to activate mechanisms that help repair neural circuitry in the prefrontal cortex and hippocampus, which get damaged as a result of depression.
Researchers provide further evidence that the cannabis compound, CBD, is effective at reducing seizures in people with epilepsy. The new study reveals CBD significantly reduced seizures in people with Lennox-Gastaut syndrome. Previously, the researchers demonstrated CBD was effective at seizure control in Dravet syndrome.
A new study reveals cannabinoid medications may not reduce pain itself, but instead make pain feel less unpleasant and more tolerable.
People with the specific genotype of the Cannabinoid receptor 1 gene may be more prone to cannabis use disorder. Researchers report those with FAAH rs324420 A continue to want more marijuana following use and are more drawn to cannabis-related imagery while under the influence of the drug.
